BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19825847)

  • 1. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration.
    Hecker LA; Edwards AO; Ryu E; Tosakulwong N; Baratz KH; Brown WL; Charbel Issa P; Scholl HP; Pollok-Kopp B; Schmid-Kubista KE; Bailey KR; Oppermann M
    Hum Mol Genet; 2010 Jan; 19(1):209-15. PubMed ID: 19825847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic complement activation in age-related macular degeneration.
    Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
    PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.
    Silva AS; Teixeira AG; Bavia L; Lin F; Velletri R; Belfort R; Isaac L
    Mol Vis; 2012; 18():2288-99. PubMed ID: 22969267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration.
    Krilis M; Qi M; Qi J; Wong JWH; Guymer R; Liew G; Hunyor AP; Madigan M; McCluskey P; Weaver J; Krilis SA; Giannakopoulos B
    Free Radic Biol Med; 2018 Dec; 129():237-246. PubMed ID: 30253188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
    Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
    Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
    Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
    JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related macular degeneration: Complement in action.
    van Lookeren Campagne M; Strauss EC; Yaspan BL
    Immunobiology; 2016 Jun; 221(6):733-9. PubMed ID: 26742632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Activation Levels Are Related to Disease Stage in AMD.
    Heesterbeek TJ; Lechanteur YTE; Lorés-Motta L; Schick T; Daha MR; Altay L; Liakopoulos S; Smailhodzic D; den Hollander AI; Hoyng CB; de Jong EK; Klevering BJ
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):18. PubMed ID: 32176267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.
    Loyet KM; Deforge LE; Katschke KJ; Diehl L; Graham RR; Pao L; Sturgeon L; Lewin-Koh SC; Hollyfield JG; van Lookeren Campagne M
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6628-37. PubMed ID: 22930722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation.
    Williamson JF; McLure CA; Guymer RH; Baird PN; Millman J; Cantsilieris S; Dawkins RL
    Genomics; 2011 Dec; 98(6):412-21. PubMed ID: 21855625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration.
    Shen D; Tuo J; Patel M; Herzlich AA; Ding X; Chew EY; Chan CC
    Br J Ophthalmol; 2009 Mar; 93(3):405-8. PubMed ID: 18996904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.
    Salman A; McClements ME; MacLaren RE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.
    Park KH; Ryu E; Tosakulwong N; Wu Y; Edwards AO
    Mol Vis; 2009; 15():200-7. PubMed ID: 19169411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of CFD polymorphisms with advanced age-related macular degeneration.
    Zeng J; Chen Y; Tong Z; Zhou X; Zhao C; Wang K; Hughes G; Kasuga D; Bedell M; Lee C; Ferreyra H; Kozak I; Haw W; Guan J; Shaw R; Stevenson W; Weishaar PD; Nelson MH; Tang L; Zhang K
    Mol Vis; 2010 Nov; 16():2273-8. PubMed ID: 21139680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in complement regulators and susceptibility to age-related macular degeneration.
    Cipriani V; Matharu BK; Khan JC; Shahid H; Stanton CM; Hayward C; Wright AF; Bunce C; Clayton DG; Moore AT; Yates JR
    Immunobiology; 2012 Feb; 217(2):158-61. PubMed ID: 22024702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFH Loss in Human RPE Cells Leads to Inflammation and Complement System Dysregulation via the NF-κB Pathway.
    Armento A; Schmidt TL; Sonntag I; Merle DA; Jarboui MA; Kilger E; Clark SJ; Ueffing M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement in AMD.
    Zipfel PF; Lauer N; Skerka C
    Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.